Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China flag China · Delayed Price · Currency is CNY
16.88
-0.29 (-1.69%)
May 20, 2026, 12:35 PM CST

SHE:300119 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,3753,3713,0452,6842,0631,987
Other Revenue
27.5627.5625.3324.9821.4420.23
3,4033,3983,0702,7092,0842,007
Revenue Growth (YoY)
6.11%10.70%13.32%29.98%3.84%0.34%
Cost of Revenue
2,0192,0041,8201,5271,075969.26
Gross Profit
1,3841,3951,2501,1821,0101,038
Selling, General & Admin
703.96708.73640.33584.43486.89529.17
Research & Development
249.12251.74196.04172.47132.1116.64
Other Operating Expenses
26.4523.1121.8920.0420.418.97
Operating Expenses
1,0081,012874.82803.78659.1682.72
Operating Income
375.81382.25375.04378.65350.43355.16
Interest Expense
-35.16-35.16-31.21-25.42-28.43-23.82
Interest & Investment Income
45.7736.7114.1120.8115.2524.27
Currency Exchange Gain (Loss)
-0.14-0.140.780.510.41-0.28
Other Non Operating Income (Expenses)
3.4-7.6-5.59-6.120.43-3.21
EBT Excluding Unusual Items
389.68376.06353.12368.42338.1352.12
Gain (Loss) on Sale of Investments
55.675.83-10.7161.2651.38113.8
Gain (Loss) on Sale of Assets
3.823.82-0.02114.09-0.010.1
Asset Writedown
-1.65-1.3-0.14-0.47-0.11-9.1
Other Unusual Items
16.2716.2726.0427.8922.1630.88
Pretax Income
463.72470.69368.29571.19413.81487.79
Income Tax Expense
31.9536.2238.4656.1840.0454.2
Earnings From Continuing Operations
431.77434.47329.83515373.77433.59
Minority Interest in Earnings
-39.47-33.96-29.11-61.41-27.07-20.81
Net Income
392.31400.51300.72453.59346.7412.78
Net Income to Common
392.31400.51300.72453.59346.7412.78
Net Income Growth
20.19%33.18%-33.70%30.83%-16.01%3.66%
Shares Outstanding (Basic)
454454460464463402
Shares Outstanding (Diluted)
454454460464463402
Shares Change (YoY)
-1.04%-1.29%-0.69%0.11%15.06%1.61%
EPS (Basic)
0.860.880.650.980.751.03
EPS (Diluted)
0.860.880.650.980.751.03
EPS Growth
21.46%34.93%-33.24%30.69%-27.00%2.02%
Free Cash Flow
72.97121.43550.21158.4717.0576.75
Free Cash Flow Per Share
0.160.271.200.340.040.19
Dividend Per Share
0.4000.4000.3000.4000.3000.350
Dividend Growth
33.33%33.33%-25.00%33.33%-14.29%-12.50%
Gross Margin
40.67%41.04%40.71%43.65%48.44%51.71%
Operating Margin
11.04%11.25%12.22%13.98%16.81%17.70%
Profit Margin
11.53%11.79%9.80%16.74%16.63%20.57%
Free Cash Flow Margin
2.14%3.57%17.92%5.85%0.82%3.82%
EBITDA
590.41592.74569.07517.4457.89439.13
EBITDA Margin
17.35%17.44%18.54%19.10%21.97%21.88%
D&A For EBITDA
214.6210.49194.03138.76107.4583.97
EBIT
375.81382.25375.04378.65350.43355.16
EBIT Margin
11.04%11.25%12.22%13.98%16.81%17.70%
Effective Tax Rate
6.89%7.70%10.44%9.84%9.68%11.11%
Revenue as Reported
3,3983,3983,0702,7092,0842,007
Advertising Expenses
-16.1713.047.446.647.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.